GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Rhino Biotech Ltd (OTCPK:RBRXF) » Definitions » 12-1 Month Momentum %

Rhino Biotech (Rhino Biotech) 12-1 Month Momentum % : N/A% (As of Jun. 23, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Rhino Biotech 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-23), Rhino Biotech's 12-1 Month Momentum % is N/A%.

The industry rank for Rhino Biotech's 12-1 Month Momentum % or its related term are showing as below:

RBRXF's 12-1 Month Momentum % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 3.93
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Rhino Biotech's 12-1 Month Momentum %

For the Shell Companies subindustry, Rhino Biotech's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhino Biotech's 12-1 Month Momentum % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Rhino Biotech's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Rhino Biotech's 12-1 Month Momentum % falls into.



Rhino Biotech  (OTCPK:RBRXF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhino Biotech  (OTCPK:RBRXF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Rhino Biotech 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Rhino Biotech's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhino Biotech (Rhino Biotech) Business Description

Traded in Other Exchanges
N/A
Address
294 Heywood House, British West Indies, Anguilla, AIA
Rhino Biotech Ltd formerly Eurasia Energy Ltd is a shell company.
Executives
Nicholas W Baxter 10 percent owner 220 SPRINGFIELD ROAD, ABERDEEN, ABERDEENSHIRE, SCOTLAND X0 AB15 6AU
Graham Crabtree officer: Chief Financial Officer 294 HEYWOOD HOUSE SOUTH HILL 1A AI-2640
Roger Thomas director 22 HENDERSON ROAD LONDON X0 SW18 3RR
Velda King director, officer: President, C.E.O. SUITE C102 10000 NORTH 31ST AVENUE PHOENIX AZ 85051
Gerald R Tuskey director, officer: C.F.O., Secretary/Treasurer 570 GRANVILLE STREET SUITE 400 VANCOUVER BC A1 V6C 3P1

Rhino Biotech (Rhino Biotech) Headlines

From GuruFocus

Rhino Biotech to Present at the Planet Microcap Showcase

By ACCESSWIRE ACCESSWIRE 05-04-2022